Back to User profile » Dr Muhammad Ayaz
Papers published by Dr Muhammad Ayaz:
Analagesic and Anti-Inflammatory Potentials of a Less Ulcerogenic Thiadiazinethione Derivative in Animal Models: Biochemical and Histochemical Correlates
Rahman K, Ali G, Khan R, Khan I, Ali I, Mosa OF, Ahmed A, Ayaz M, Nawaz A, Murthy HCA
Drug Design, Development and Therapy 2022, 16:1143-1157
Published Date: 21 April 2022
Synthesis of Michael Adducts as Key Building Blocks for Potential Analgesic Drugs: In vitro, in vivo and in silico Explorations
Ahmad S, Mahnashi MH, Alyami BA, Alqahtani YS, Ullah F, Ayaz M, Tariq M, Sadiq A, Rashid U
Drug Design, Development and Therapy 2021, 15:1299-1313
Published Date: 23 March 2021
Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives
Ahmad A, Ullah F, Sadiq A, Ayaz M, Saeed Jan M, Shahid M, Wadood A, Mahmood F, Rashid U, Ullah R, Sahibzada MUK, Alqahtani AS, Mahmood HM
Drug Design, Development and Therapy 2020, 14:2165-2178
Published Date: 3 June 2020
In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5- trans-docosenoate Isolated from Anchusa arvensis (L.) M.Bieb. Against HepG-2 Cancer Cells
Hussain S, Ullah F, Ayaz M, Ali Shah SA, Ali Shah AH, Shah SM, Wadood A, Aman W, Ullah R, Shahat AA, Nasr FA
Drug Design, Development and Therapy 2019, 13:4195-4205
Published Date: 10 December 2019
Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies
Ahmad A, Ullah F, Sadiq A, Ayaz M, Rahim H, Rashid U, Ahmad S, Jan MS, Ullah R, Shahat AA, Mahmood HM
Drug Design, Development and Therapy 2019, 13:4185-4194
Published Date: 10 December 2019